Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID

NCT07661862 is registered in ClinicalTrials.gov with University of Tasmania as lead sponsor.

NCT NCT07661862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07661862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID
Lead sponsor
University of Tasmania
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2026
Completion date
April 1, 2029
Enrollment
577 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

long covid